Back
Monopar Therapeutics Stock Price Chart
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.
Sell
31
MNPR
Monopar Therapeutics
Last Price:
$32.88
Seasonality Move:
-27.37%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.23 | Sell |
| 20-day SMA: | 34.66 | Sell |
| 50-day SMA: | 36.88 | Sell |
| 200-day SMA: | 26.2 | Buy |
| 8-day EMA: | 34.36 | Sell |
| 20-day EMA: | 35.08 | Sell |
| 50-day EMA: | 36.02 | Sell |
| 200-day EMA: | 28.02 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.88 | Sell |
| Relative Strength Index (14 RSI): | 44.51 | Sell |
| Chaikin Money Flow: | -17891 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.82 - 37.44) | Sell |
| Bollinger Bands (100): | (32.07 - 43.25) | Sell |
Monopar Therapeutics Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 33.52 while MNPR 8-day simple moving average is 35.23, which is a Sell signal.
-
The stock price of MNPR is 33.52 while Monopar Therapeutics 20-day SMA is 34.66, which makes it a Sell.
-
Monopar Therapeutics 50-day simple moving average is 36.88 while MNPR share price is 33.52, making it a Sell technically.
-
MNPR stock price is 33.52 and Monopar Therapeutics 200-day simple moving average is 26.20, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Sell
31
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a SellThe current Monopar Therapeutics [MNPR] share price is $33.52. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
205M
Price in USD:
33.52
Share Volume:
42.2K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Sell
31
Monopar Therapeutics (MNPR)
is a Sell
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 33.52 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 33.52 while MNPR 8-day exponential moving average is 34.36, which is a Sell signal.
-
The stock price of MNPR is 33.52 while Monopar Therapeutics 20-day EMA is 35.08, which makes it a Sell.
-
Monopar Therapeutics 50-day exponential moving average is 36.02 while MNPR share price is 33.52, making it a Sell technically.
-
MNPR stock price is 33.52 and Monopar Therapeutics 200-day simple moving average is 28.02, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.11 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is -0.88, suggesting Monopar Therapeutics is a Sell
-
Monopar Therapeutics Relative Strength Index (RSI) is 44.51, which suggest Monopar Therapeutics is oversold
-
The Bollinger Bands (25) for Monopar Therapeutics is (32.82 - 37.44), which suggest Monopar Therapeutics is a Sell
-
The Bollinger Bands (100) for Monopar Therapeutics is (32.07 - 43.25), which suggest Monopar Therapeutics is a Sell
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.